Quick Answer
IOVANCE BIOTHERAPEUTICS, INC. reported Shares Outstanding of 411.94 million shares for fiscal year 2025.
IOVANCE BIOTHERAPEUTICS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 411.94M | +35.0% |
| 2024 | 305.25M | +19.2% |
| 2023 | 256.14M | +36.4% |
| 2022 | 187.81M | +19.6% |
| 2021 | 157.00M | +6.2% |
| 2020 | 147.87M | +17.0% |
| 2019 | 126.41M | +2.4% |
| 2018 | 123.42M | +68.7% |
| 2017 | 73.16M | +17.5% |
| 2016 | 62.25M | +28.2% |
| 2015 | 48.55M | +43.8% |
| 2014 | 33.75M | +68.5% |
| 2013 | 20.02M | +2345.5% |
| 2012 | 818,806 | -99.0% |
| 2011 | 77.99M | +5.9% |
| 2010 | 73.64M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 385.46M | +26.5% | +12.7% |
| June 30, 2025 | 341.92M | +15.0% | +2.4% |
| March 31, 2025 | 333.93M | +19.4% | +9.4% |
| December 31, 2024 | 305.25M | +19.2% | +0.2% |
| September 30, 2024 | 304.62M | +19.1% | +2.5% |
| June 30, 2024 | 297.31M | +32.3% | +6.3% |
| March 31, 2024 | 279.76M | +24.7% | +9.2% |
| December 31, 2023 | 256.14M | +36.4% | +0.1% |
- IOVANCE BIOTHERAPEUTICS, INC. showed an increase of +35.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, IOVANCE BIOTHERAPEUTICS, INC.’s shares outstanding has grown by 459.4% (from 73.64 million shares to 411.94 million shares).
- The most recent figure is from IOVANCE BIOTHERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: